| Authors: |
Menotti M; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.; Cell Signalling Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK., Ambrogio C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cheong TC; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Pighi C; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Mota I; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Cassel SH; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Biomedical and Biological Sciences Program, Harvard Medical School, Boston, MA, USA.; Medical Scientist Training Program, Harvard Medical School, Boston, MA, USA., Compagno M; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Wang Q; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Dall'Olio R; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Minero VG; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Poggio T; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Sharma GG; School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy., Patrucco E; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Mastini C; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Choudhari R; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.; Center of Emphasis in Cancer, Paul L. Foster School of Medicine, Department of Biomedical Sciences, Texas Tech University Health Sciences Center, El Paso, TX, USA., Pich A; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Zamo A; Department of Oncology, University of Torino, Torino, Italy., Piva R; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Giliani S; Nocivelli Institute for Molecular Medicine, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Mologni L; School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy., Collings CK; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kadoch C; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Gambacorti-Passerini C; School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy., Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Anton IM; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain., Voena C; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy. claudia.voena@unito.it., Chiarle R; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy. roberto.chiarle@childrens.harvard.edu.; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. roberto.chiarle@childrens.harvard.edu. |
